Leadership Overview
Frontage Laboratories has 5 executives leading key functions including strategy, operations, and finance.
Driven by scientific rigor, Frontage Laboratories is dedicated to accelerating drug development through integrated, science-driven product development services, enabling pharmaceutical and biotechnology companies to achieve their development goals and advance critical molecules through regulatory submissions globally.
Driven by scientific rigor, Frontage Laboratories is dedicated to accelerating drug development through integrated, science-driven product development services, enabling pharmaceutical and biotechnology companies to achieve their development goals and advance critical molecules through regulatory submissions globally.
Leadership Roles at Frontage Laboratories
Jonathan Lin - Co-Chief Executive Officer
Jonathan Lin, the Co-Chief Executive Officer at Frontage Laboratories, directs the overarching strategy and operational execution for the company's comprehensive drug discovery and development services. Lin guides the integration of science-driven solutions across the entire product development lifecycle, ensuring Frontage Laboratories effectively supports pharmaceutical and biotechnology clients in achieving their development objectives. This leadership involves fostering innovation in areas such as drug metabolism and pharmacokinetics, analytical testing, and formulation development. Jonathan Lin also oversees the expansion of services, including preclinical safety and toxicology assessment and early phase clinical studies, to meet evolving industry demands. The focus remains on enabling clients to advance molecules through development and secure regulatory submissions in key global markets. Lin's strategic direction ensures Frontage Laboratories maintains its position as a leading CRO, facilitating the progression of numerous molecules through critical development stages.
Daniella Kranjac - Co-Chief Executive Officer
Daniella Kranjac, the Co-Chief Executive Officer at Frontage Laboratories, spearheads the strategic vision and global expansion initiatives for the contract research organization. Kranjac drives the company's mission to provide integrated, science-driven product development services, enabling pharmaceutical and biotechnology partners to achieve their critical development goals. This involves overseeing the comprehensive suite of services, from drug discovery through to regulatory submissions, including bioanalysis, preclinical safety, and early phase clinical studies. Daniella Kranjac ensures that Frontage Laboratories remains at the forefront of scientific innovation, adapting to the complex needs of advancing molecules through development. The leadership focuses on enhancing client success by optimizing processes in areas like drug metabolism and pharmacokinetics and formulation development. Kranjac's strategic oversight is crucial for maintaining Frontage Laboratories' competitive edge and facilitating the successful progression of client projects across the United States, China, and other international markets.
Zhongping Lin - Co-Chief Executive Officer
Zhongping Lin, the Co-Chief Executive Officer at Frontage Laboratories, drives the strategic direction and operational excellence across the company's diverse service offerings. Lin is instrumental in ensuring the seamless integration of science-driven solutions that support pharmaceutical and biotechnology clients throughout their product development journey. This encompasses a broad spectrum of services, including drug metabolism and pharmacokinetics, analytical testing, formulation development, and manufacturing of preclinical and clinical trial materials. Zhongping Lin's leadership ensures that Frontage Laboratories consistently delivers high-quality bioanalysis, preclinical safety, and toxicology assessments. The focus is on enabling clients to efficiently advance molecules through development and achieve successful regulatory submissions in the United States, China, and other global regions. Lin's strategic vision reinforces Frontage Laboratories' commitment to accelerating drug development and achieving client objectives.
Huan Wang - Interim Chief Financial Officer
Huan Wang, the Interim Chief Financial Officer at Frontage Laboratories, oversees the financial strategy and fiscal management of the contract research organization. Wang ensures robust financial planning and analysis to support the company's integrated, science-driven product development services. This leadership role involves managing financial operations that enable pharmaceutical and biotechnology companies to achieve their development goals, from drug discovery through to regulatory submissions. Huan Wang's responsibilities include overseeing the financial aspects of bioanalysis, preclinical safety, toxicology assessment, and early phase clinical studies. The focus is on maintaining financial stability and optimizing resource allocation across all service areas, including drug metabolism and pharmacokinetics, analytical testing, and formulation development. Wang's financial stewardship is critical for Frontage Laboratories' continued growth and success in advancing client molecules through development.
Min Wang - Chief Operating Officer
Min Wang, the Chief Operating Officer at Frontage Laboratories, directs the day-to-day operational execution of the company's integrated drug development services. Wang ensures the efficient delivery of comprehensive solutions, including drug metabolism and pharmacokinetics, analytical testing, and formulation development, supporting pharmaceutical and biotechnology clients in achieving their development goals. This operational leadership encompasses the management of bioanalysis, preclinical safety, and toxicology assessment services, ensuring scientific rigor and regulatory compliance. Min Wang oversees the manufacturing of preclinical and clinical trial materials, critical for advancing molecules through development. The focus is on optimizing internal processes to enhance client success and facilitate regulatory submissions in the United States, China, and other key markets. Wang's role is vital in maintaining the high standards of service delivery that Frontage Laboratories provides.
Explore Leadership Teams in Business Services
The National Laboratory of the Rockies, located in Golden, Colorado, is a national laboratory of the United States Department of Energy specializing in energy systems research and development. Formerly known as the National Renewable Energy Laboratory until December 2025, NLR serves as the primary federal laboratory for advancing energy technologies across the entire energy spectrum, from generation to distribution to end use. The laboratory conducts multidisciplinary research in renewable energy, energy efficiency, energy systems integration, sustainable transportation, bioenergy, photovoltaics, wind energy, hydrogen and fuel cells, energy storage, and advanced materials science. NLR operates state-of-the-art research facilities including the Energy Systems Integration Facility, Solar Energy Research Facility, and maintains high-performance computing capabilities. The laboratory partners with industry, government agencies, academia, and other national laboratories to bridge foundational research with practical applications. NLR develops data sets, analytical tools, and models for energy technology analysis while working to lower energy costs, drive economic growth, strengthen national security, and ensure abundant energy for the nation. The laboratory maintains campuses in Golden and Arvada, Colorado, as well as Fairbanks, Alaska, and is operated under contract for the Department of Energy's Office of Critical Minerals and Energy Innovation by the Alliance for Sustainable Energy.
Company Leadership KA

GH
JL
A wholly-owned company of the Malaysian Government under the Minister of Finance Incorporated, SIRIM Berhad is a premier Research and Technology organisation providing timely and focused research. SIRIM Berhad is also the champion of Quality and has gained international recognition in Standards and Conformity Assessment, underlying its mission "as a Leader in Quality and Technology Development.
Company Leadership DN
HS
AZ
Nuziveedu Seeds Limited (NSL) is a prominent seed company in India, recognized for its excellence in research and development. The company specializes in breeding programs that genetically enhance crops, focusing on field crops, fiber crops, and vegetable crops. With a commitment to quality and innovation, NSL supports farmer productivity through advanced seed technology and extensive processing facilities. NSL serves millions of farmers across South Asia, positioning itself as a trusted ally in agriculture.
Company Leadership AS
KA
SV
SA
The Savannah River National Laboratory is a multi-program national laboratory for the U.S. Department of Energys Office of Environmental Management. SRNL is located at the Savannah River Site near Jackson, South Carolina. It was founded in 1951, as the Savannah River Laboratory. It was certified as a national laboratory on May 7, 2004.
Company Leadership BS
MF
AD
DH